Skip to main content

Deerfield Management Company, L.P.'s Form 4 filing

Oncorus, Inc. (ONCR) · filed Dec 21, 2022

Accession no.
0001193805-22-001764
Filed
Dec 21, 2022, 7:09 PM ET
Trade date
Dec 19-21, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 9 non-derivative transactions. Open-market sales total $37.6K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Deerfield Management Company, L.P.CIK 000100925810% Owner, Other: *Possible Member of 10% Group
Deerfield Mgmt L.P.CIK 000101082310% Owner, Other: *Possible Member of 10% Group
Deerfield Partners, L.P.CIK 000130104110% Owner, Other: *Possible Member of 10% Group
Flynn James ECIK 000135254610% Owner, Other: *Possible Member of 10% Group
Deerfield Private Design Fund III, L.P.CIK 000160333310% Owner, Other: *Possible Member of 10% Group
Deerfield Mgmt III, L.P.CIK 000161054010% Owner, Other: *Possible Member of 10% Group
Deerfield Healthcare Innovations Fund, L.P.CIK 000164698110% Owner, Other: *Possible Member of 10% Group
Deerfield Mgmt HIF, L.P.CIK 000166573610% Owner, Other: *Possible Member of 10% Group

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 19, 2022Common StockSSaleDisposed−44,394$0.29F1−$12,874.261,351,374Indirect
Dec 19, 2022Common StockSSaleDisposed−44,394$0.29F1−$12,874.261,351,374Indirect
Dec 19, 2022Common StockSSaleDisposed−10,930$0.29F1−$3,169.7332,725Indirect
Dec 20, 2022Common StockSSaleDisposed−6,562$0.31F2−$2,034.221,344,812Indirect
Dec 20, 2022Common StockSSaleDisposed−6,562$0.31F2−$2,034.221,344,812Indirect
Dec 20, 2022Common StockSSaleDisposed−1,616$0.31F2−$500.96331,109Indirect
Dec 21, 2022Common StockSSaleDisposed−6,144$0.30F3−$1,843.21,338,668Indirect
Dec 21, 2022Common StockSSaleDisposed−6,143$0.30F3−$1,842.91,338,669Indirect
Dec 21, 2022Common StockSSaleDisposed−1,513$0.30F3−$453.9329,596Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.28 to $0.30, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-3 of this Form 4.

Referenced by the price of 3 transactions in Table I.

F2

The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.30 to $0.32, inclusive.

Referenced by the price of 3 transactions in Table I.

F3

The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.29 to $0.30, inclusive.

Referenced by the price of 3 transactions in Table I.

Remarks

Jonathan Isler, Attorney-in-Fact: Power of Attorney, which is hereby incorporated by reference to Exhibit 24 to a Form 4 with regard to DA32 Life Science Tech Acquisition Corp. filed with the Securities and Exchange Commission on August 3, 2021 by Deerfield Partners, L.P., Deerfield Mgmt, L.P., Deerfield Management Company, L.P. and James E. Flynn.

Read the full filing on SEC EDGAR (opens in a new tab)